Optimizing Large-Scale COVID-19 Nucleic Acid Testing with a Dynamic Testing Site Deployment Strategy

Abstract

The COVID-19 epidemic has spread worldwide, infected more than 0.6 billion people, and led to about 6 million deaths. Conducting large-scale COVID-19 nucleic acid testing is an effective measure to cut off the transmission chain of the COVID-19 epidemic, but it calls for deploying numerous nucleic acid testing sites effectively. In this study, we aim to optimize the large-scale nucleic acid testing with a dynamic testing site deployment strategy, and we propose a multiperiod location-allocation model, which explicitly considers the spatial–temporal distribution of the testing population and the time-varied availability of various testing resources. Several comparison models, which implement static site deployment strategies, are also developed to show the benefits of our proposed model. The effectiveness and benefits of our model are verified with a real-world case study on the Chenghua district of Chengdu, China, which indicates that the optimal total cost of the dynamic site deployment strategy can be 15% less than that of a real plan implemented in practice and about 2% less than those of the other comparison strategies. Moreover, we conduct sensitivity analysis to obtain managerial insights and suggestions for better testing site deployment in field practices. This study highlights the importance of dynamically deploying testing sites based on the target population’s spatial–temporal distribution, which can help reduce the testing cost and increase the robustness of producing feasible plans with limited medical resources.

Redesigning the Drugs Distribution Network: The Case of the Italian National Healthcare Service

“…The distribution stage is usually performed by hospital pharmacies or community pharmacies, or by temporary points of dispensing, providing medicine and medical supplies (vaccines, drugs, and therapeutics) to patients. Prescriptive analytics has mostly considered facility location problems [20][21][22][23][24][25][26]. The involvement of community pharmacies in the drug distribution model is reported to support the increase in the population's access to drugs, reduce costs, and provide fair access to patients.…”

“…The model is applied to the case of 333 geographical centers of towns across Beijing demonstrating its applicability. Similarly, He et al [26] focus on testing sites, i.e., on a unique item to be distributed, to optimize the site deployment strategy considering the spatial-temporal distribution of the testing population and the time-varied availability of testing resources. The model is tested through a real-world case study in the Chenghua district of Chengdu, China, demonstrating that dynamic deployment contributes to cost reduction.…”

Effectiveness Analysis of Large-Scale Infectious Virus Detection Strategy Based on SEIQR Model

“…Zeng Ting et al [7] proposed a random COVID-19 model with large-scale nucleic acid detection and isolation measures. He Xiaozhou et al [8] optimized large-scale nucleic acid detection through dynamic detection site deployment strategy, proposed a multi-period location allocation model, and proved that the optimal total cost of the strategy is lower than the actual implementation scheme. Zhu Wenlong et al [9] used the branch process model to evaluate different management strategies.…”